These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1369547)

  • 1. [Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature].
    Delozier T; Vernhes JC
    Bull Cancer; 1991 Nov; 78(11):1013-25. PubMed ID: 1369547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model.
    Alderton PM; Gross J; Green MD
    Cancer Res; 1992 Jan; 52(1):194-201. PubMed ID: 1727379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer.
    Pavesi L; Preti P; Da Prada G; Pedrazzoli P; Poggi G; Robustelli della Cuna G
    Anticancer Res; 1995; 15(2):495-501. PubMed ID: 7763029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
    Toda K; Asaishi K; Okazaki M; Okazaki Y; Okazaki A; Sato H; Mikami T; Watanabe Y; Hayasaka H; Narimatsu E
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3011-4. PubMed ID: 2782905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin].
    Yayoi E; Furukawa J; Takatsuka Y; Kobayashi T; Aikawa T; Maeura Y; Kaji M; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1621-4. PubMed ID: 1530320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adriamycin in chemotherapy of solid tumors].
    Lovisetto P; Pochettino G; Biarese V
    Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mitoxantrone in a combination regimen in advanced breast cancer].
    Hausmaninger H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):594-7. PubMed ID: 4096006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer].
    Taguchi T; Sakai K; Terasawa T; Wada H
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2820-8. PubMed ID: 3530139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial of mitoxantrone (novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast cancer.
    Büyükünal E; Derman U; Serdengecti S; Berkarda B
    Chemioterapia; 1987 Oct; 6(5):377-9. PubMed ID: 3322590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer].
    Inoue K; Ogawa M; Inagaki J; Horikoshi N; Ikeda K; Nakada H; Usui N; Adachi K; Tada A; Yamazaki H
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1832-7. PubMed ID: 6433805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
    Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of doxorubicin versus epirubicin in advanced breast cancer.
    Brambilla C; Rossi A; Bonfante V; Ferrari L; Villani F; Crippa F; Bonadonna G
    Cancer Treat Rep; 1986 Feb; 70(2):261-6. PubMed ID: 3456271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K; Wakui A; Saito T; Tominaga T; Niitani H; Fujimoto T; Masaoka T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity of mitoxantrone].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3040-5. PubMed ID: 3464231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K; Fukuoka M; Yamamoto M; Kawahara M; Tsuruta M; Kodama N; Arai R; Hayashi S; Kiyota M; Kubota K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring].
    Okuma K; Ariyoshi Y; Ota K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1893-900. PubMed ID: 3164181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.